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Abstract
Feeding behavior is governed by homeostatic needs and motivational drive to obtain palatable 
foods. Here, we identify a population of glutamatergic neurons in the paraventricular thalamus, 
which express the glucose transporter Glut2 (Scl2a2) and project to the nucleus accumbens. These 
neurons are activated by hypoglycemia and, in freely moving mice, their activation by 
optogenetics or Slc2a2 inactivation increases motivated sucrose but not saccharin-seeking 
behavior. These neurons may control sugar overconsumption in obesity and diabetes.
The brain depends almost exclusively on glucose as a source of metabolic energy. Sufficient 
provision of glucose to the brain is ensured by homeostatic mechanisms, which maintain 
glycemia at a minimal level of ~ 5 mM 1 and by hedonic mechanisms, which attribute a high 
reward value to glucose-containing foods to increase the motivation to consume them 2, 3. 
In this hedonic response the nucleus accumbens plays a central regulatory role by integrating 
feeding-related inputs originating from several brain areas 4–11.
In previous studies, we showed that Glut2 expression in the nervous system (NG2KO mice) 
is required for the control by glucose of the sympathetic and parasympathetic nerve 
activities 12. Here, we tested whether neuronal Glut2-dependent glucose-sensing was also 
involved in motivated feeding behavior. NG2KO mice and control littermates were 
monitored during operant conditioning tasks, which associate nose poking behavior with a 
light stimulus (conditioned stimulus, CS+) and the delivery of a sweet reward (10% sucrose 
solution). In a first set of experiments, mice were trained for 30 minutes daily for 10 days on 
a fixed ratio 1 schedule of reinforcement (FR1) where they learned to associate the CS+ with 
sweet reward. Appetitive learning was observed in both genotypes since reward obtained and 
active nosepokes performed increased over time (Fig. 1a,b) whereas inactive nosepokes 
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remained similarly low in NG2KO mice and control mice (Suppl. Fig. 1a) indicating similar 
learning capacity. However, NG2KO mice performed better in this task (Fig. 1a,b). Next, we 
subjected mice to a progressive ratio (PR) schedule, which consisted of a systematic within-
session increase in the number of nosepokes required to earn each successive reward. 
NG2KO mice again performed better, with higher number of active nosepokes, of rewards 
obtained, and a higher maximal operant response (breakpoint) indicating higher motivation 
(Fig. 1c-e). Similar behavioral tasks were then performed with the non-caloric artificial 
sweetener saccharin. In FR1 (Fig. 1f,g) and PR (Fig. 1h-j) experiments NG2KO mice and 
control mice performed identically indicating that neuronal Glut2-dependent glucose sensing 
responds to sucrose and is insensitive to artificial sweeteners.
Operant conditioning is associated with activity of the nucleus accumbens (NAc) 13, 14. We 
therefore investigated whether Glut2-positive neurons or axons could be observed in the 
NAc using Slc2a2-cre;Rosa26tdtomato mice 15. We observed numerous red fibers within 
the medial part of the NAc, mainly close to the anterior commissure and around the ventral 
end of the lateral ventricle (Suppl. Fig. 2a). To determine the origin of those fibers, we 
performed retrograde tracing experiments in which the cholera toxin B subunit-AlexaFluor 
488 conjugate (CTxB) was injected bilaterally in the NAc of Slc2a2-cre;Rosa26tdtomato 
mice (Fig. 2a and Suppl. Fig. 2b). Three weeks later, we screened the entire brain for 
tdtomato cell bodies labeled with CTxB. No colabeling with the rare Glut2-neurons present 
in the ventral tegmental area, the prefrontal cortex, the hippocampus or the different 
hypothalamic nuclei could be found. Co-labeled cells were found only in the paraventricular 
thalamic nucleus (PVT) (Fig. 2b) where 91 ± 1.7% of the PVT Glut2 neurons were also 
labeled with CTxB.
Next, we assessed whether the firing activity of tdtomato positive neurons was responsive to 
changes in extracellular glucose concentrations (Fig. 2c). In the presence of 5 mM glucose 
these neurons showed a low basal activity, which was markedly enhanced in the presence of 
0.5 mM glucose. Returning the glucose to 5 mM restored the initial firing activity (Fig. 2d-
f). The same glucose-dependent increase in firing activity was seen in the presence a cocktail 
of synaptic inhibitors indicating that glucose-sensing is cell-autonomous (Suppl. Fig. 3a). 
When glycolysis was inhibited by 10 mM glucosamine in the presence of 5 mM glucose, 
firing was significantly increased (Fig. 2g-i). Fructose at 5 mM failed to suppress firing 
induced by 0.5 mM glucose (Suppl. Fig. 3b). Finally, patch clamp analysis of Glut2 neurons 
from mice previously injected with 2-deoxy-D-glucose showed that their firing frequency at 
5 mM glucose was identical to that seen during exposure to 0.5 mM glucose of Glut2-
neurons from naïve mice and did not change when glucose was lowered to 0.5 mM (Fig. 2j-
l). Tdtomato negative cells were also recorded in the presence of 5 or 0.5 mM glucose; they 
were found to be unresponsive to hypoglycemia (Suppl. Fig. 3c). Thus, PVT Glut2 neurons 
are activated by low glucose concentrations or by glycolysis inhibition; their firing rate 
cannot be suppressed by fructose, and they are responsive to in vivo induced 
neuroglucopenia.
To investigate the nature of Glut2 projections to the NAc, Slc2a2-cre mice were injected in 
the PVT with an AAV-DIO-ChR2-eYFP 16 (Fig. 3a). Brain slices obtained three weeks later 
displayed numerous eYFP-positive neurons in the PVT and fibers in the NAc (Fig. 3b,c). 
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Electrophysiological recordings from medium spiny neurons (MSNs) of the NAc together 
with local light-stimulation of the ChR2-expressing terminals (Fig. 3c) revealed postsynaptic 
inward currents (Fig. 3d), which could be totally abolished by tetrodotoxin, a blocker of 
action potential-dependent neurotransmitter release (Fig. 3d,e). The typical fast kinetics of 
those inward currents suggested they were α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic receptors (AMPARs) excitatory post-synaptic currents (EPSCs). This 
was confirmed by the application of the AMPAR antagonist DNQX that entirely suppressed 
light-induced EPSCs in all the cells tested (Fig. 3f-g). Thus, light-stimulation of NAc-
projecting PVT Glut2-neurons triggers glutamate release onto NAc MSNs.
To test the functional role of the PVT Glut2 excitatory inputs onto the NAc, we used an 
operant conditioning protocol associated with in vivo optogenetic activation of these 
neurons. Slc2a2-cre mice and control mice were injected in the PVT with an AAV-DIO-
ChR2-eYFP and equipped with a fiber-optic cannula. Following recovery, mice were tested 
during operant conditioning to obtain sucrose. At the beginning of each behavioral session, 
mice were connected to a light source via an optical fiber and stimulated during the entire 
duration of the session. During the training/learning period (FR1 schedule), the ChR2-
expressing mice consumed significantly more reward (Fig. 3h) and performed more active 
nosepokes (Fig. 3i) than the control mice. Moreover, during the progressive ratio schedule 
mice expressing ChR2 showed increased motivated sucrose-seeking behavior by obtaining 
more rewards and showing increased breakpoint (Fig. 3j,k). To confirm that increased 
motivated behavior was light-dependent we tested the same mice in a progressive ratio 
schedule one month later without light stimulation. No difference in motivated behavior was 
seen between genotypes (Suppl. Fig. 4b,c). A similar experiment was repeated but with light 
stimulation through fiber-optic cannulas placed bilaterally at the NAc level. Light 
stimulation increased motivated sucrose seeking behavior as assessed in FR1 and 
progressive ratio schedules (Suppl. Fig. 5). When tested three days later without light 
stimulation, the breakpoint value of control mice remained the same and ChR2-expressing 
mice exhibited similar motivation as controls. Note that learning during the FR1 protocol 
was slower as compared to the previous experiment (Fig 3h,i), probably because these mice 
were implanted with two (instead of one) optical fibers, which may hamper access to the 
nosepoke holes.
Finally, we inactivated Slc2a2 selectively in the PVT of Slc2a2loxP/loxP mice by stereotactic 
injection of an AAV-Cre-GFP (Fig 3l). PCR analysis of genomic DNA extracted from the 
PVT and fluorescence microscopy analysis confirmed proper injection of the virus and 
recombination of Slc2a2floxed allele in the AAV-Cre-GFP injected mice (Suppl. Fig. 6). 
These mice displayed increased motivation to get sucrose compared to control mice as 
reflected by the higher number of rewards and increased breakpoint (Fig. 3m,n).
Collectively, our data show that Glut2-neurons from the PVT and projecting to the NAc 
form a population of hypoglycemia-activated, glutamatergic neurons, which induce EPSCs 
in MSN neurons. Their firing rate can be increased by glycolysis inhibition, but cannot be 
suppressed by fructose, indicating that they are controlled by glucose metabolism. When 
activated by hypoglycemia, optogenetics, or by Slc2a2 inactivation, they increase motivated 
sugar-feeding behavior indicating a dominant role in motivated sugar seeking. The possible 
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relevance of these results to human physiology is suggested by the observations that mild 
hypoglycemia induces marked increase in synaptic activity in this part of the thalamus 17 
and that variants in SLC2A2 are associated with increased intake of sugar-containing foods 
18 and conversion from impaired glucose tolerance to type 2 diabetes 19. This newly 
identified neuronal pathway may, thus, represent a new target for the prevention of metabolic 
disease aiming at restoring the normal balance between the homeostatic and hedonic control 
of food intake.
Online Methods
Mice
All procedures were approved by the veterinary office of Canton de Vaud (Switzerland) 
under the veterinary license number VD2513. Slc2a2loxP/loxP, Slc2a2Δ/loxP;NesCre/+ 
(NG2KO), Slc2a2-cre and Slc2a2-cre;Rosa26tdtomato mice were as described 
previously20–22. NG2KO and Slc2a2loxP/loxP mice were on a mixed C57BL/6;SV129 
background; Slc2a2-cre and Glut2-cre;Rosa26tdtomato mice were on a C57BL/6 
background. All studies used littermates as controls. For all experiments, mice were age-
matched and randomly assigned to experimental groups to ensure a non-biased animals 
distribution. No blinding was used. Unless otherwise stated, animals were collectively 
housed (maximum 5 individuals per cage) on a 12-hour light/dark cycle (lights on at 7 am) 
and fed with a standard chow (Diet 3436, Provimi Kliba AG).
Viral vectors
All viral constructs were produced by the Vector Core of the Gene Therapy Center at the 
University of North Carolina (UNC, North Carolina, USA).
Operant conditioning
Adult NG2KO males and control littermates (10 to 15 weeks old) were housed individually 
under a 12-h reversed light/dark cycle (lights on at 8:30 pm) at a constant temperature (22 
± 1°C) and had ad libitum access to water. Starting from the first day of experiment, mice 
were slightly food restricted and received ~3 g of laboratory chow per day. No more than 
15 % of body weight reduction over the entire duration of the experiment was allowed. Mice 
were trained in operant conditioning chambers (Med Associates) under a fixed ratio 1 
schedule of reinforcement (FR1) during 30-min daily sessions. Animals had choice between 
two nosepoke ports, an active nosepoke hole associated with a 3-sec light cue and a 
concomitant delivery of a liquid reward through a central spout equipped with infrared head 
entry detector and an inactive nosepoke hole that remained inoperative. Each active 
nosepoke triggered the delivery of 10 µl of a 10 % sucrose or 0.2 % saccharin solution. 
Liquid rewards remained available for 3 sec once access to the central spout was detected. 
Supplementary entries in the active nosepoke in the absence of head entry detection above 
the liquid dipper and entries in the inactive nosepoke were recorded but had no further 
consequence. After a training period of 7 to 10 days, the animals were engaged into three 
consecutive sessions (one 90 min session per day) under a progressive-ratio schedule of 
reinforcement (PR). Under this schedule the mice were required to progressively increase 
the number of active nosepokes between two successive rewards based on the progression 
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sequence given by23: response ratio (rounded to nearest integer) = (5e(reward× 0.2)) − 5. 
Hence, the progressive-ratio schedule followed the progression: 1, 2, 4, 6, 9, 12, 15, 20, 25, 
32, 40, 50, 62, 77, 95, 118, 145, 178, 219, etc. The maximal number of active nosepokes 
performed to reach the final ratio was defined as the breakpoint, a value reflecting animals’ 
motivation to get the reward. Active/inactive nosepokes and reward obtained were monitored 
online using an analog/digital interface coupling the operant chambers to a computer 
running the MED-PC behavioral software suite (Med Associates).
Neuronal retrograde tracing
Four adult Slc2a2-cre;Rosa26tdtomato males (10 weeks old) were anesthetized with 
isoflurane (5% (w/v) for induction followed by 2.5% for maintenance (Attane, Piramal 
Healthcare)) and placed in a stereotaxic frame (David Kopf Instruments). Nucleus 
accumbens (NAc) was infused bilaterally with cholera toxin subunit B (CTxB) conjugated 
with AlexaFluor 488 (Molecular Probes, Life Technologies). The following stereotaxic 
coordinates were used: AP +1.5 / ML ± 1.4 / DV -4,5 mm (10° angle). A volume of 0.4 µl of 
0.25 % CTxB solution was injected in each hemisphere through 33 Gauge stainless steel 
injector (Hamilton) coupled to a precision pump (Harvard Apparatus) with a injection rate of 
0.1 µl . min-1. Two weeks later, animals were anesthetized (isoflurane) and perfused 
transcardially with a 0.1 M phosphate buffer (PBS, pH 7.4) followed by 4% 
paraformaldehyde in PBS. The perfused brains were dissected and postfixed with 4% 
paraformaldehyde in PBS at 4 °C for 1 h and then placed overnight at 4 °C in a solution 
containing 30% sucrose in PBS. Brains were frozen in isopentane and maintained at -20 °C 
until further analysis. Twenty-five micrometers cryosections were prepared (Leica) and 
mounted onto glass slides with Mowiol anti-fade medium (Sigma-Aldrich). Images were 
taken using an Axio Imager D1 microscope interfaced with a Axiovision software or a LSM 
510 Meta inverted confocal laser scanning microscope with LSM software 3.5 (Zeiss). For 
neuronal quantification, four sections containing PVT were screened in each mouse (n = 4) 
and Glut2 neurons were counted (n = 891) to determine which percentage of those neurons 
were colabeled with CTxB. Injection sites were verified for each mouse at the end of the 
experiment.
Electrophysiology
4 to 8 weeks old males used for electrophysiology were deeply anesthetized with isoflurane 
prior to decapitation, brain removed and immediately submerged in a ice-cold slushy ACSF 
solution saturated with 95 % O2 / 5 % CO2 containing (in mM): 125 NaCl, 2.5 KCl, 1.25 
NaH2PO4, 1 MgCl2, 2 CaCl2, 26 NaHCO3, 12.5 sucrose and 5 mM glucose (300 ± 5 
mOsm). Acute coronal sections (250 µm) containing PVT or NAc were obtained using a 
vibratome (VT1000S; Leica) and maintained at 32°C for at least 1 h before recording. 
Experiments were performed using an upright epifluorescence microscope (BX51WI; 
Olympus) mounted on a motorized stage and coupled to micromanipulators (Sutter 
instruments). Brain slices were placed in a recording chamber and continuously superfused 
at a rate of 2 ml . min-1 with oxygenated ACSF maintained at 32 - 34 °C. Borosilicate 
pipettes (resistance = 3 to 5 MΩ; Harvard Apparatus) were shaped with a horizontal 
micropipette puller (Sutter Instruments). Firing rate of PVT neurons at different extracellular 
glucose concentrations (5 or 0.5 mM) was monitored after a 10-15 min baseline through 
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loose cell-attached recordings in current-clamp mode using a MultiClamp 700B amplifier 
(Molecular Devices). Intra-pipette solution contained (in mM): 130 potassium gluconate, 10 
HEPES, 0.2 EGTA, 5 NaCl, 1 MgCl, 10 Na-phosphocreatinine, 4 MgATP and 0.5 Na2GTP 
(pH 7.2-7.3, 275 ± 5 mOsm). When mentioned in the text, a cocktail of synaptic inhibitors 
was used and was composed of picrotoxin (100 µM; GABAA receptor antagonist), DNQX 
(10 µM; AMPA and kainate receptor antagonist), DL-AP5 (100 µM; NMDA receptor 
antagonist) and strychnine (1 µM; glycine receptor antagonist)(Tocris Bioscience). For ex 
vivo optogenetic experiments in medium spiny neurons of the NAc, neurons were voltage 
clamped at −70 mV in whole-cell configuration and light-induced currents were recorded 
with a intra-pipette solution containing (in mM): 117 cesium methanesulfonate, 20 HEPES, 
0.4 EGTA, 2.8 NaCl, 5 TEA-Cl, 2.5 MgATP and 0.5 Na2GTP (pH 7.2-7.3, 275 ± 5 mOsm). 
Blue light (473 nm) pulses were delivered on the brain slice through the microscope 
objective. TTX 1 µM and DNQX 10 µM were bath applied in the perfusion chamber. 
Currents traces were constructed by averaging 15 consecutive photocurrents. Signals were 
filtered at 2 kHz, digitized at 10 kHz and collected online using a pClamp 10 data 
acquisition system (Molecular Devices).
Optogenetics
10 to 12 weeks old adult Slc2a2-cre or Slc2a2+/+ males were used for optogenetics 
experiments. Under isoflurane anesthesia mice were placed in a stereotaxic frame (David 
Kopf Instruments) and PVT was infused with the viral vector rAAV2-Ef1α- DIO-
hChR2(H134R)-eYFP (titer = 3.08 x 1012 particles . ml-1) to allow the expression of 
channelrhodopsin-2 in a Cre-dependent manner (0.25 µl delivered at 0.1 µl . min-1). To 
ensure a good expression of the ChR2 in the entire PVT the virus was injected at two 
coordinates: AP -0.4 / ML +0.8 / DV -3.5 mm and AP -1.6 / ML +0.7 / DV -3 mm with a 
10° angle to avoid the damage to the superior sagittal sinus. Three weeks after viral injection 
mice were either used for ex vivo electrophysiological experiments or involved in in vivo 
operant conditioning behavioral tasks as described above. For ex vivo experiments, 4 ms 
light pulses were delivered by a high-power collimated blue LED system (M470L2-C1 + 
LEDD1B; Thorlabs) through the optical path of the microscope. For in vivo experiments, 
optical fiber cannulas (Precision Fiber Products) were lowered either unilaterally in PVT 
(AP -0.4 / ML +0.8 / DV -3.4 mm, 10° angle) or bilaterally in NAc (AP +1.5 / ML ±1.35 / 
DV -4.2 mm, 10° angle) and fixed to the skull with surgical screws (PlasticsOne), tissue 
adhesive (VetBond; 3M) and dental cement (Paladur; Heraeus-Kulzer). A DSPP laser 
(LRS-0473-GFM-00100-05; Laserglow Technologies) was used to deliver light pulses (10 
ms light pulses at 20 Hz, 1 s on/1s off, 10-15 mW) through an optical fiber (0.22 NA, 200 
µm core diameter; Doric Lenses) that was attached to the optic cannula at the beginning of 
each experimental session (FR1 or PR). Light-stimulation was applied during the entire 
duration of the experimental session. To avoid the optical fiber from twisting and to allow 
mice to move freely, a rotary joint (FRJ 1×1; Doric Lenses) was placed outside the operant 
chamber right on top of the animal. Injection sites and optical fiber cannula placement were 
verified for each mouse at the end of the experiment.
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PVT Glut2 deletion
10 to 15 weeks old adult Slc2a2loxP/loxP males were injected with the viral vectors rAAV5-
Cre-GFP (titer = 5 x 1012 particles . ml-1) or rAAV5-TRUFR-GFP (titer = 6.9 x 1012 
particles . ml-1) at the following injections sites: AP -0.4 / ML +0.8 / DV -3.5 mm (10° 
angle) and AP -1.6 / ML +0.7 / DV -3.0 mm (10° angle). Each injection consisted in an 
infusion of 0.25 µl virus at a speed of 0.1 µl . min-1. At the end of the operant conditioning 
experiments, mice were anesthetized (isoflurane), sacrificed and deletion of Glut2 was 
determined via PCR amplification of genomic DNA from dissected brain tissue containing 
PVT as previously described24. PCR amplification gels were made in duplicates. Injection 
site was verified for each mouse at the end of the experiment.
Statistical analysis
Statistical significance was calculated using GraphPad Prism 5.0c (GraphPad Software). The 
sample size for each experiment was determined based on published studies using similar 
experimental design together with pilot experiments from our laboratory. This allowed us to 
determined the sample size required for each experiment to ensure a statistical power of 0.8 
and an alpha level of 0.05. Two-sided Student's t-tests were used to analyze statistical 
significance between two experimental groups. To ensure variance similarity between 
compared groups, a Fischer's F-test was performed before each t-test. When multiple 
comparisons was required, one-way or two-way ANOVA was performed followed by a 
Bonferroni's post-hoc test. The data distribution was assumed to be normal. Data are 
represented as means ± s.e.m. The levels of statistical significance are indicated as follow: 
*** P<0.001 ; ** P<0.01 ; * P<0.05.
Data availability
Data are available upon request from the first author (Bernard.Thorens@unil.ch).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Inactivation of Slc2a2 enhances motivated sucrose-seeking behavior.
In operant conditioning experiments, under fixed ratio schedule (FR1), NG2KO mice (n=18) 
showed higher performance to obtain a sucrose reward as compared to control mice (n=22). 
a, Rewards obtained (30-min daily session). b, Active nosepokes (Reward: genotype effect, 
F(1,341) = 47.29, P<0.0001; interaction, F (9,341) = 0.65, P = 0.7574; Active nosepokes: 
genotype effect, F(1,341) = 29.07, P<0.0001; interaction, F (9,341) = 0.38, P = 0.9449; two-
way ANOVA followed by Bonferroni’s test). Under progressive ratio (PR) schedule, 
NG2KO mice showed higher motivation to obtain sucrose as shown by c, the total number of 
rewards (P = 0.0314), d, the number of active nosepokes (P = 0.0320), and e, the breakpoint 
(P = 0.03; t-test). With saccharin as reward (0.2% solution) NG2KO (n=17) and control (n= 
19) littermates behaved identically in FR1 (f, g) (Reward: genotype effect, F(1,335) = 0.47, 
P = 0.4915; interaction, F (9,335) = 0.67, P = 0.7403; Active nosepokes: genotype effect, 
F(1,335) = 0.14, P = 0.7111; interaction, F (9,335) = 0.42, P = 0.9235; two-way ANOVA 
followed by Bonferroni’s test), or PR (h-j) schedule, (P>0.05, t-test). Graphs show means ± 
s.e.m; boxplots show median, lower and upper quartiles (box), and minimum and maximum 
(whiskers). *** P<0.001 ; * P<0.05 ; n.s.: non significant.
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Figure 2. PVT Glut2 neurons project to NAc and respond to hypoglycemia.
a, Schematic of the experimental approach. CTxB was bilaterally injected in the NAc of 
Slc2a2-cre;Rosa26tdtomato mice. b, CTxB (green) was found to co-localize with tdtomato-
positive Glut2 neurons (red) only in the PVT area. c, Slc2a2-cre;Rosa26tdtomato mice were 
used to prepare acute brain slices containing the PVT Glut2 neurons for patch-clamp 
analysis. Inset shows microscopic view of a patched Glut2 neuron (red); white dashed lines 
delimit the recording pipette. d, Neuronal activity recorded in cell-attached configuration 
from a PVT Glut2 neuron in the presence of the indicated extracellular glucose 
concentrations. e, Mean firing frequency monitored under the different extracellular glucose 
(Glc) concentrations (n = 16 neurons in 7 mice). Hypoglycemia induced a significant 
increase of the firing rate (F(2,15) = 14.49, P<0.0001; one-way ANOVA followed by a 
Bonferroni’s test). f, Individual plots of firing frequency for the neurons described in panel 
e. g,h, D-glucosamine (GLN) induced an increase of the Glut2 neuronal activity despite the 
presence of 5 mM extracellular glucose (n = 8 neurons in 4 mice; F(2,7) = 7.9, P = 0.0051; 
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one-way ANOVA followed by a Bonferroni’s test). i, Individual plots for neurons described 
in panel h. j, Neuroglucopenia induced by i.p. 2-DG 45 min prior to sacrifice increased 
neuronal activity of PVT Glut2 neurons. k, Mean firing frequency monitored under the 
indicated extracellular glucose concentrations (n = 15 neurons in 8 mice). Injection of 2-DG 
increased the firing activity in the presence of 5 mM glucose and blunted the response to 
hypoglycemia (compare with e) (F(2,14) = 0.11, P = 0.8976; one-way ANOVA followed by 
a Bonferroni’s test). l, Individual plots for neurons described in panel k. Boxplots show 
median, lower and upper quartiles (box), and minimum and maximum (whiskers). Nucleus 
accumbens (NAc), paraventricular thalamic nucleus (PVT) and third ventricule (3V). : *** 
P<0.001 ; ** P<0.01 ; * P<0.05 ; n.s.: non significant.
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Figure 3. PVT Glut2 neurons are glutamatergic and control motivated sucrose-seeking behavior.
a, Schematic of the experimental approach. ChR2 was virally delivered in PVT of Slc2a2-
cre or control mice (Slc2a2+/+). b, Epifluorescence microscopy picture of ChR2-positive 
neurons (green fluorescence, YFP) in the PVT of a Slc2a2-cre mouse. c, Schematic of the 
experimental protocol. NAc medium spiny neurons (blue circles) were recorded while distal 
axons of PVT Glut2 neurons (green fluorescence) were photostimulated in the NAc of a 
Slc2a2-cre mouse transfected with ChR2 in the PVT. d, Example of light-induced currents 
obtained during baseline condition (black trace) or in the presence of tetrodotoxin (TTX, 1 
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μM, grey trace). Blue rectangles indicate light pulse (4 ms, 473 nm). e, Mean amplitude of 
light-induced currents recorded in NAc medium spiny neurons in baseline condition or with 
TTX (n = 7, P = 0.0002, paired t-test). f, Example of light-induced currents obtained during 
baseline condition (black trace) or in the presence of the AMPAR antagonist DNQX (10 μM, 
grey trace). g, Similar to e with DNQX instead of TTX (n = 13, P<0.0001, paired t-test). h,i, 
FR1 operant conditioning for sucrose coupled with in vivo light stimulation of Glut2 PVT 
neurons in control (grey circles, n = 13) or Slc2a2-cre mice (white circles, n = 15) which 
received prior PVT injection of AAV-DIO-ChR2. Blue rectangles indicate light pulses (473 
nm, 10 ms light pulses at 20 Hz, 1 s on/1s off). Light-evoked neuronal activation increased 
operant responses to obtain sucrose (Reward: genotype effect, F(1,182) = 32.79, P<0.0001; 
interaction, F (6,182) = 1.16, P = 0.3282; Active nosepokes: genotype effect, F(1,182) = 
38.57, P<0.0001; interaction, F (6,182) = 1.49, P = 0.1830; two-way ANOVA followed by 
Bonferroni’s test). j, Mean sucrose reward and k, breakpoint value monitored under 
progressive ratio schedule with in vivo light stimulation of Glut2 PVT neurons in control 
(grey boxes) or Slc2a2-cre mice (white boxes)(P = 0.0011 and P = 0.0042, respectively; t-
test). l, Schematic view of the experimental approach. AAV-Cre-GFP or the control construct 
AAV-GFP was injected in PVT of Slc2a2loxP/loxP mice (n = 17 and n = 18 respectively). m, 
Mean sucrose reward and n, breakpoint value monitored under progressive ratio schedule in 
Slc2a2loxP/loxP injected with AAV-GFP (grey boxes) or AAV-Cre-GFP (white boxes)(P = 
0.0347 and P = 0.0213, respectively; t-test). Graphs show means ± s.e.m; Boxplots show 
median, lower and upper quartiles (box), and minimum and maximum (whiskers). Nucleus 
accumbens core (AcbC), shell (AcbSh), lateral ventricule (LV) and anterior commissure 
(aca). *** P<0.001 ; ** P<0.01 ; * P<0.05.
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